Inflammatory mediators in chronic heart failure: an overview.
作者信息
Anker Stefan D, von Haehling Stephan
机构信息
Department of Clinical Cardiology, Imperial College School of Medicine, National Heart & Lung Institute, London, UK.
出版信息
Heart. 2004 Apr;90(4):464-70. doi: 10.1136/hrt.2002.007005.
Abstract
摘要
相似文献
1
Inflammatory mediators in chronic heart failure: an overview.慢性心力衰竭中的炎症介质：综述
Heart. 2004 Apr;90(4):464-70. doi: 10.1136/hrt.2002.007005.
2
[Anticytokine therapy in the treatment of patients with chronic heart failure].[抗细胞因子疗法治疗慢性心力衰竭患者]
Kardiologiia. 2010;50(5):77-83.
3
The emerging use of TNF-alpha inhibitors in orbital inflammatory disease.肿瘤坏死因子-α抑制剂在眼眶炎性疾病中的新兴应用。
Int Ophthalmol Clin. 2006 Spring;46(2):165-81. doi: 10.1097/00004397-200604620-00014.
4
TNF-alpha inhibitors and congestive heart failure.肿瘤坏死因子-α抑制剂与充血性心力衰竭
Skinmed. 2005 Nov-Dec;4(6):363-8. doi: 10.1111/j.1540-9740.2005.04502.x.
5
[Anti-TNF-alpha therapy for heart failure: etanercept, infliximab].用于心力衰竭的抗肿瘤坏死因子-α疗法：依那西普、英夫利昔单抗
Nihon Rinsho. 2007 May 28;65 Suppl 5:176-81.
6
[TNF alpha in the physiopathology of psoriasis].[肿瘤坏死因子α在银屑病病理生理学中的作用]
Ann Dermatol Venereol. 2006 Feb;133(2):174-80. doi: 10.1016/s0151-9638(06)70873-0.
7
The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure.肿瘤坏死因子α阻断剂在充血性心力衰竭治疗中的作用。
Congest Heart Fail. 2002 Sep-Oct;8(5):275-9. doi: 10.1111/j.1527-5299.2002.01155.x.
8
9
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.如何从“复兴”中恢复？“恢复（RECOVER）”“复兴（RENAISSANCE）”“更新（RENEWAL）”和“附加（ATTACH）”研究结果的意义。
Int J Cardiol. 2002 Dec;86(2-3):123-30. doi: 10.1016/s0167-5273(02)00470-9.
10
Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH.临床试验更新：RENEWAL（复兴和康复）及ATTACH
Eur J Heart Fail. 2002 Aug;4(4):559-61. doi: 10.1016/s1388-9842(02)00121-6.
引用本文的文献
1
Prognostic impact of systemic immune inflammatory index in patients with reduced ejection fraction heart failure.全身免疫炎症指数对射血分数降低的心力衰竭患者的预后影响
BMC Cardiovasc Disord. 2025 Jul 31;25(1):559. doi: 10.1186/s12872-025-05053-4.
2
The role of the gut microbiota and metabolites in heart failure and possible implications for treatment.肠道微生物群和代谢产物在心力衰竭中的作用及其对治疗的潜在影响。
Heart Fail Rev. 2025 Jul 25. doi: 10.1007/s10741-025-10546-7.
3
Sex Hormone-Binding Globulin and Cardiac Function in Men with Heart Failure: Possible Role of Diabetes.心力衰竭男性患者的性激素结合球蛋白与心脏功能：糖尿病的可能作用
J Clin Med. 2025 Mar 21;14(7):2132. doi: 10.3390/jcm14072132.
4
The expression profile analysis and functional prediction of lncRNAs in peripheral blood mononuclear cells in maintenance hemodialysis patients developing heart failure.维持性血液透析心力衰竭患者外周血单个核细胞 lncRNAs 表达谱分析及功能预测。
Sci Rep. 2024 Nov 28;14(1):29577. doi: 10.1038/s41598-024-81080-z.
5
Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects.靶向 MuRF1 防治心脏恶病质骨骼肌丢失：机制与治疗前景。
Med Sci Monit. 2024 Oct 22;30:e945211. doi: 10.12659/MSM.945211.
6
Prognostic value of lymphocyte to C-reactive protein ratio for cardiovascular and all-cause mortality in adults with congestive heart failure in the United States: NHANES 1999-2010.淋巴细胞与C反应蛋白比值对美国充血性心力衰竭成人患者心血管及全因死亡率的预后价值：1999 - 2010年美国国家健康与营养检查调查（NHANES）
Heliyon. 2024 Sep 25;10(19):e38416. doi: 10.1016/j.heliyon.2024.e38416. eCollection 2024 Oct 15.
7
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight.肺动脉高压与右心室：病理生理学见解
Clin Med Insights Cardiol. 2024 Sep 9;18:11795468241274744. doi: 10.1177/11795468241274744. eCollection 2024.
8
Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge.小肠细菌过度生长（SIBO）与十二组相关疾病——当前知识状况
Biomedicines. 2024 May 7;12(5):1030. doi: 10.3390/biomedicines12051030.
9
Extracellular vesicles mediate inflammasome signaling in the brain and heart of Alzheimer's disease mice.细胞外囊泡介导阿尔茨海默病小鼠大脑和心脏中的炎性小体信号传导。
Front Mol Neurosci. 2024 Apr 10;17:1369781. doi: 10.3389/fnmol.2024.1369781. eCollection 2024.
10
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Acute Decompensated Heart Failure: A Meta-Analysis.中性粒细胞与淋巴细胞比值在急性失代偿性心力衰竭患者中的预后价值：一项荟萃分析
J Clin Med. 2024 Feb 21;13(5):1212. doi: 10.3390/jcm13051212.
本文引用的文献
1
Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.肿瘤坏死因子-α与心力衰竭——病理生理学及治疗意义
Basic Res Cardiol. 2004 Jan;99(1):18-28. doi: 10.1007/s00395-003-0433-8. Epub 2003 Aug 21.
2
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.肿瘤坏死因子-α嵌合单克隆抗体英夫利昔单抗治疗中重度心力衰竭的随机、双盲、安慰剂对照试验：抗TNF治疗充血性心力衰竭（ATTACH）试验结果
Circulation. 2003 Jul 1;107(25):3133-40. doi: 10.1161/01.CIR.0000077913.60364.D2. Epub 2003 Jun 9.
3
Statins and the role of nitric oxide in chronic heart failure.他汀类药物与一氧化氮在慢性心力衰竭中的作用
Heart Fail Rev. 2003 Jan;8(1):99-106. doi: 10.1023/a:1022103222857.
4
Inflammatory mediators and the failing heart: past, present, and the foreseeable future.炎症介质与衰竭心脏：过去、现在及可预见的未来
Circ Res. 2002 Nov 29;91(11):988-98. doi: 10.1161/01.res.0000043825.01705.1b.
5
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.慢性心力衰竭患者全血中内毒素诱导的肿瘤坏死因子-α释放的病理生理量。
Am J Cardiol. 2002 Dec 1;90(11):1226-30. doi: 10.1016/s0002-9149(02)02839-4.
6
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.如何从“复兴”中恢复？“恢复（RECOVER）”“复兴（RENAISSANCE）”“更新（RENEWAL）”和“附加（ATTACH）”研究结果的意义。
Int J Cardiol. 2002 Dec;86(2-3):123-30. doi: 10.1016/s0167-5273(02)00470-9.
7
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.白细胞介素-10对慢性心力衰竭患者外周血单个核细胞肿瘤坏死因子-α产生的影响。
Am J Cardiol. 2002 Aug 15;90(4):384-9. doi: 10.1016/s0002-9149(02)02494-3.
8
B-cell function in chronic heart failure: antibody response to pneumococcal vaccine.慢性心力衰竭中的B细胞功能：对肺炎球菌疫苗的抗体反应
J Card Fail. 2001 Dec;7(4):318-21. doi: 10.1054/jcaf.2001.27829.
9
Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.左心室机械支持后人类终末期心力衰竭中核因子-κB的可逆性激活
Cardiovasc Res. 2002 Jan;53(1):124-30. doi: 10.1016/s0008-6363(01)00433-3.
10
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.静脉注射免疫球蛋白对慢性心力衰竭患者的免疫调节治疗
Circulation. 2001 Jan 16;103(2):220-5. doi: 10.1161/01.cir.103.2.220.
Zotero 插件